MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer

MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer

Summary: Advanced prostate cancers are treated with therapies targeting the androgen receptor (AR) signaling pathway. While many tumors initially respond to AR inhibition, nearly all develop resistance. It is critical to understand how prostate tumor cells respond to AR inhibition in order to exploi...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Preston D. Crowell, Jenna M. Giafaglione, Anthony E. Jones, Nicholas M. Nunley, Takao Hashimoto, Amelie M.L. Delcourt, Anton Petcherski, Raag Agrawal, Matthew J. Bernard, Johnny A. Diaz, Kylie Y. Heering, Rong Rong Huang, Jin-Yih Low, Nedas Matulionis, Nora M. Navone, Huihui Ye, Amina Zoubeidi, Heather R. Christofk, Matthew B. Rettig, Robert E. Reiter, Michael C. Haffner, Paul C. Boutros, Orian S. Shirihai, Ajit S. Divakaruni, Andrew S. Goldstein
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Elsevier 2023-10-01
Loạt:Cell Reports
Những chủ đề:
CP: Cancer
CP: Metabolism
Truy cập trực tuyến:http://www.sciencedirect.com/science/article/pii/S2211124723012330

Internet

http://www.sciencedirect.com/science/article/pii/S2211124723012330

Những quyển sách tương tự